Show simple item record

dc.contributorKhandekar, R.EN
dc.contributorMohammed, A.J.EN
dc.date.accessioned2014-06-17T11:29:18Z
dc.date.available2014-06-17T11:29:18Z
dc.date.issued2003EN
dc.identifier.issn1020-3397EN
dc.identifier.otherhttp://applications.emro.who.int/emhj/0905_6/9_5-6_2003_1026_1033.pdfEN
dc.identifier.urihttp://www.who.int/iris/handle/10665/119358
dc.description1026-1033EN
dc.description.abstractA prospective cohort study was made of 386 first-grade primary-school children in Oman with active trachoma and 386 matched controls without trachoma. All children were educated about trachoma prevention. In addition, trachoma cases were treated with a single dose of oral azithromycin [‎20 mg/kg]‎. Trachoma status was evaluated after 6 weeks, 6 months and 12 months. The follicles and inflammatory signs of active trachoma resolved 6 weeks or more after azithromycin treatment. The protection against subsequent trachoma infection cycles was optimal at 6 months [‎85.2% of cases, 99.0% of controls infection-free]‎ but declined at 12 months [‎66.7% of cases, 98.2% of controls infection-free]‎. Clinical evaluation seems to be a useful tool to evaluate the response of azithromycin to active trachoma cases in schoolchildren in a country with limited resourcesEN
dc.language.isoenEN
dc.subjectAdministration, OralEN
dc.subjectAnti-Bacterial AgentsEN
dc.subjectDrug Administration ScheduleEN
dc.subjectMass ScreeningEN
dc.subjectPhysical ExaminationEN
dc.subjectSchool Health ServicesEN
dc.subjectSingle-Blind MethodEN
dc.subjectTime FactorsEN
dc.subjectTrachomaEN
dc.subjectTreatment OutcomeEN
dc.subject.meshAzithromycinEN
dc.titleOutcome of azithromycin treatment of active trachoma in Omani schoolchildrenEN
dc.relation.ispartofjournalEMHJ - Eastern Mediterranean Health Journal, 9 (‎5-6)‎, 1026-1033, 2003


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record